A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

NCT06894459 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancers

Interventions

DRUG: Pembrolizumab
DRUG: Cisplatin
DRUG: Nab-paclitaxel

Sponsor

Beijing Tongren Hospital